Peptide Clinical Trials intermediate
MDM2/MDMX Inhibitor
Field
By Encyclopeptide Editorial | 1 min read
peptide-clinical-trials peptide oligopeptide
Overview
MDM2/MDMX Inhibitor is a peptide compound with applications in research and therapeutics. Field
Chemical Identity
| Property | Value |
|---|---|
| Name | MDM2/MDMX Inhibitor |
| Sequence | --- |
Rimegepant - Migraine (NCT03235479) |
| Length | 44 amino acids |
| Category | Peptide Clinical Trials |
Structure
MDM2/MDMX Inhibitor belongs to the Peptide Clinical Trials class of peptides. Its structure and properties make it suitable for various research and therapeutic applications.
Applications
MDM2/MDMX Inhibitor has been studied for its potential applications in:
- Biomedical research
- Drug discovery
- Diagnostic applications
- Therapeutic development
References
- Source: peptide-clinical-trials.md
- Database: Wikipept Peptide Database
Test Your Knowledge
Reinforce what you learned about MDM2/MDMX Inhibitor with interactive quizzes on Wikipept.
Take a Quiz on Wikipept